Ex vivo expansion of lung cancer‐derived disseminated cancer cells from lymph nodes identifies cells associated with metastatic progression

URN to cite this document:: urn:nbn:de:bvb:355-epub-545883
DOI to cite this document:: 10.5283/epub.54588

Treitschke, Steffi ; Weidele, Kathrin ; Varadarajan, Adithi Ravikumar ; Feliciello, Giancarlo ; Warfsmann, Jens ; Vorbeck, Sybille ; Polzer, Bernhard ; Botteron, Catherine ; Hoffmann, Martin ; Dechand, Vadim ; Mederer, Tobias

; Weber, Florian

; Werner‐Klein, Melanie ; Robold, Tobias ; Hofmann, Hans‐Stefan ; Werno, Christian ; Klein, Christoph A.

License: Creative Commons Attribution 4.0
PDF
Early View
(6MB)

Date of publication of this fulltext: 17 Aug 2023 06:04

Alternative links to fulltext:DOI Publisher

This publication is part of the DEAL contract with Wiley.

Details

Preview: Early View

Export bibliographical data

Abstract

The cellular basis of the apparent aggressiveness in lung cancer is poorly understood but likely associated with functional or molecular features of disseminated cancer cells (DCCs). DCCs from epithelial cancers are mostly detected by antibodies directed against histogenetic markers such as cytokeratin or EpCAM. It has been argued that marker-negative metastatic founder cells might escape ...